NOVAN INC (NOVN)
US66988N2053 - Common Stock
NOVAN INC
NASDAQ:NOVN (7/25/2023, 7:00:02 PM)
After market: 0.0894 0 (-4.99%)0.0941
-0.03 (-24.84%)
Company Profile
Novan, Inc. is a medical dermatology company, which engages in the development and commercialization of therapeutic products for skin diseases. The company is headquartered in Durham, North Carolina and currently employs 89 full-time employees. The company went IPO on 2016-09-21. The firm is focused on developing and commercializing therapeutic products for skin diseases. The firm is engaged in developing SB206 (berdazimer gel, 10.3%) as a topical prescription gel for the treatment of viral skin infections, with a focus on molluscum contagiosum (molluscum). The firm's commercial portfolio includes six branded prescription drugs. The company actively promotes three medical dermatological products in the United States, such as Wynzora (calcipotriene and betamethasone dipropionate), Rhofade (oxymetazoline hydrochloride), and Minolira (minocycline hydrochloride). Wynzora is a combination of calcipotriene, a vitamin D analog, and betamethasone dipropionate, a corticosteroid, indicated for the topical treatment of plaque psoriasis. Rhofade is an alpha1A adrenoceptor agonist indicated for the topical treatment of persistent facial erythema. Minolira is indicated to treat inflammatory lesions.
Company Info
NOVAN INC
4020 Stirrup Creek Drive, Suite 110
Durham NORTH CAROLINA 27703
P: 19194858080.0
CEO: Paula Brown Stafford
Employees: 89
Website: https://novan.com/
NOVN News
10 months ago - Seeking AlphaNovan craters as company files for bankruptcy, to sell most of its assets (NASDAQ:NOVN)Novan (NOVN) shares plummeted -68.7% on Monday after the company said it had filed for bankruptcy and entered into a deal to sell most of its assets to Ligand Pharmaceuticals (LGND) for...
10 months ago - Novan, Inc.Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection– The Company and Ligand Pharmaceuticals sign agreement to sell substantially all of Novan’s assets under Section 363 of the U.S. Bankruptcy Code, along...
NOVN Twits
Here you can normally see the latest stock twits on NOVN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
